Study on How Pre-Workout Supplements Affect Shooting Accuracy in Trained Basketball Players

NCT06995209 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-05-29

No results posted yet for this study

Summary

Basketball is a popular team sport where athletes score points by successfully shooting the ball into the basket. Accuracy in shooting is crucial for players to score points effectively. Pre-workout supplements (PWS) have garnered interest from athletes and fitness enthusiasts due to the purported synergistic action of their ingredients which, when consumed before training, may help improve athletic performance. The acute effect of PWS or similar on the shooting accuracy of basketball athletes has not yet been investigated. Therefore, this study aimed to investigate the acute effect of a caffeine-based PWS (containing caffeine, creatine, β-alanine, citrulline malate, and BCAAs) on the stationary free throw, two-point, and three-point shooting accuracy in basketball players.

Conditions

  • Athletic Performance

Interventions

DIETARY_SUPPLEMENT

Placebo

20 g, \~74 Kcal, 97% flavored maltodextrin, similar in color, flavor, taste, and energy as PWS

DIETARY_SUPPLEMENT

Pre-workout Supplement

20 g, \~73 Kcal, 200 mg caffeine, 3.3 g creatine monohydrate, 3.2 g β-alanine, 6 g citrulline malate, and 5 g branched chained amino acid (BCAA)

Sponsors & Collaborators

  • International Hellenic University

    lead OTHER

Principal Investigators

  • Sousana K. Papadopoulou · International Hellenic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-05-30
Completion
2025-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06995209 on ClinicalTrials.gov